TAPLITUMOMAB PAPTOX

UNII: AR3ULB33ZZ
Preferred Substance Name: TAPLITUMOMAB PAPTOX

235428-87-2
IMMUNOGLOBULIN G1, ANTI-(HUMAN ANTIGEN CD19) (MOUSE MONOCLONAL B43 G1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL B43 K-CHAIN, DIMER, DISULFIDE WITH PROTEIN PAP (POKEWEED ANTIVIRAL)
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD19 (ANTIGEN)) (MOUSE MONOCLONAL B43 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL B43 .KAPPA.-CHAIN, DIMER, DISULFIDE WITH PROTEIN PAP (POKEWEED ANTIVIRAL)
TAPLITUMOMAB PAPTOX [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

TAPLITUMOMAB PAPTOX

Synonyms and Mappings

Resources

Note